Journal of Gene Therapy

Editorial Board

Editor-in-Chief
Dr. Clark Chin-Chung Chen
Dr. Clark Chin-Chung Chen

is an Associate Professor, Department of Surgery, University of California, USA. His research focuses on study of DNA repair and genetic alterations in brain tumors and in biomarker development and on the mechanisms of therapeutic resistance in glioblastoma and surgical delivery of viral gene therapies.

Dr. Pu Chen
Dr. Pu Chen

is the Research Chair in Nano-Biomaterials and Professor of Chemical Engineering, Nanotechnology and Physics, University of Waterloo, Canada. His research focuses on design and measure the molecular interaction, nanostructure formation and adsorption kinetics of peptides, DNA, RNA (siRNA), proteins, surfactants, polymers, metals and inorganic compounds in solution or at interfaces.

Dr. Zeger Debyser
Dr. Zeger Debyser

is the Head of the Center of Molecular Medicine at the KULeuven, Belgium. He is the member of American Society of Microbiology, International Society for Antiviral Research, European Society of Gene and Cell Therapy. His scientific expertise focuses on the molecular virology of HIV, drug development and gene therapy.

Dr. Hidde J. Haisma
Dr. Hidde J. Haisma

is the full Professor and Chairman of the division of Pharmaceutical Gene Modulation, Department of Pharmacy, University of Groningen, Netherlands. His research is devoted to the development of genetic medicines for therapeutic intervention of gene expression in patients. He is a member of the Gene Doping panel of the World Anti-Doping Agency, WADA.

Dr. Ian McNiece
Dr. Ian McNiece

is working as a Professor of Medicine at The University of Texas MD Anderson Cancer Center in Houston and he is the Director of the Cellular Therapy Laboratories (CTL), USA. His research has been focused on aspects of stem cell biology and in particular control of proliferation and differentiation of stem cells by growth factors.

Dr. Salih Sanlioglu
Dr. Salih Sanlioglu

is a Professor working at the Gene and Cell Therapy Center of Akdeniz University Hospitals and Clinics, Antalya, Turkey. His main research interest involves the development of novel gene and cell therapy modalities for patients with diabetes. He is an alumnus of the Ohio State University, Columbus, USA.

Dr. Lin Ji
Dr. Lin Ji

is a Professor in the Department of Thoracic & Cardiovascular Surgery, University of Texas M.D. Anderson Cancer Center, USA. His research focuses on understanding the biological functions & molecular mechanisms of novel tumor suppressor genes, especially those recently identified in human chromosome 3p21.3 region, oncogenes, microRNAs in lung cancer development & treatment responses.

Dr. Xu Hanmei
Dr. Xu Hanmei

is a Professor in College of Life Sciences and Technology, China Pharmaceutical University & Director for Marine Pharmacy, China. Her research interests involve cancer therapy by a way of targeting angiogenesis and stopping the growth of solid tumors. She is also engaged in anti-tumor peptide research, design anti-tumor peptide such as HM-3, AP25, et al.

Dr. Sung Wan Kim
Dr. Sung Wan Kim

is currently a Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry & Bio engineering at University of Utah, USA. He is a pioneer in drug delivery research, hydrogels, biodegradable drug conjugates and medical polymers like blood compatible polymers. His present research includes design of novel polymers for the delivery of protein drugs, cells and genes.

Dr. Xuekun Li
Dr. Xuekun Li

is working as Full Professor at Zhejiang University, China. His researches focus on, the epigenetic modulation in neural stem cells, neuronal development and neurological diseases. He has successfully established his laboratory and his research group has been extremely interested in exploring the epigenetic modulation in neurodevelopment and neurodegenerative disorders.

Dr. Ming-Li Liou
Dr. Ming-Li Liou

is a Professor in the Department of Medical Laboratory Science and Biotechnology, Yuanpei University, Taiwan. Her research interests involve molecular epidemiology and antibiotic resistance mechanisms in nosocomial pathogens. Her current research is focused on the targeting of diagnostic markers in oral diseases via metagenomic integrated platform.

Dr. Bhuvnesh K Sharma
Dr. Bhuvnesh K Sharma

is a Senior Director at ScyTek Labs. Logan, UT, USA. His current research focuses on Identifying and Validating Cancer Tissue Biomarkers, Companion Cancer Diagnostics, Cancer Stem cells, Immunological markers to envisage Tumor recurrence / Therapeutic response or residual disease monitoring into the newer developmental strategies on Personalized Cancer Therapy.

Dr. Meral Gunay-Aygun
Dr. Meral Gunay-Aygun

is an Associate Professor in the Department of Pediatrics and Genetics at Johns Hopkins University School of Medicine and McKusick-Nathans Institute of Genetic Medicine, USA. Her research interests include inborn errors of metabolism, Pediatric genetic disorders, Ciliopathies, Gray platelet syndrome and other platelet organelle formation disorders.

Dr. Benyi Li
Dr. Benyi Li

is an Associate Professor with Tenure in the Department of Urology, University of Kansas Medical Center, USA. He is an expert and the pioneer in the field of targeting the androgen receptor with small interfering RNA and nano-techniques for human prostate cancer. His research focuses on development of novel therapies for prostate cancer-specific targeted treatment.

Dr. Gonzalo Hortelano
Dr. Gonzalo Hortelano

is an Associate Professor in the Department of Pathology & Molecular Medicine and School of Biomedical Engineering at McMaster University, Canada. His research interests are cell microencapsulation as a therapeutic delivery strategy and oral gene therapy. Dr. Hortelano was the Founding President of the Spanish Society of Gene Therapy.

Dr. Stephen H. Tsang
Dr. Stephen H. Tsang

is an Associate Professor in Ophthalmology, College of Physicians & Surgeons, Columbia University Medical Center, USA. His research focuses on PDE6 signaling in degeneration, striving to develop gene and cell-based therapies for neuronal degenerations, correlating the genotypes of various human photoreceptor degenerations with clinical features by fundus autofluorescence.

Dr. Felipe Samaniego
Dr. Felipe Samaniego

is an Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, USA. His research is to dissect death receptor apoptosis pathways in cancer. His team expertise in the specific area of Fas receptor signaling & apoptosis regulation demonstrating how proteins can regulate Fas.

Dr. Lisa Baumbach-Reardon
Dr. Lisa Baumbach-Reardon

is an Associate Professor Integrated Cancer Genomics Division Director, DNA Diagnostic Laboratory in Cancer Genomics, USA, and also certified scientist in Clinical Molecular and Biochemical Genetics. Her research areas are genetic basis of African-American breast cancer molecular basis of a number of inherited neurological, neuromuscular diseases.

Dr. Libin Zhang
Dr. Libin Zhang

is currently an Associate Professor in Huazhong University of Science and Technology, China. His research interests focuses on exploring how post-transcriptional gene expression is regulated by RNA binding proteins. This work involves experimental and computational approaches to study the mechanisms of gene expression and regulation & molecular mechanisms of RNA diseases.

Dr. Ba-Bie Teng
Dr. Ba-Bie Teng

is an Associate Professor in the Research Center for Human Genetics, Institute of Molecular Medicine, University of Texas-Houston Health Science Center, USA. Her research focuses in the discovery of mechanisms contributing to the complex process of atherosclerosis, design & development of genetic, cell therapies for the treatment of atherosclerotic vascular diseases.

Dr. Sunil J. Advani
Dr. Sunil J. Advani

is an Assistant Professor in the Department of Radiation Medicine and Applied Sciences, University of California, USA. His current work focuses on developing tumor radiosensitizing approaches for locally aggressive cancers, tumor targeted viral and non-viral delivery techniques to deliver drugs, genes and microRNAs that sensitize tumors to radiotherapy.

Dr. Brenda L Fredericksen
Dr. Brenda L Fredericksen

is an Assistant Professor, University of Maryland, USA. Her research focuses on characterization of mechanisms by which viruses evade the cell-intrinsic innate immune response, determination of viral and host cell factors involved in viral mediated-neuropathogenesis and development of broad-spectrum antiviral agents for use against emerging pathogens & biothreats of viral origin.

Dr. Stephen E. Braun
Dr. Stephen E. Braun

is an Assistant Research Professor, Department of Pharmacology, Tulane National Primate Research Center, USA. His research focus on intersection of gene therapy, hematopoietic stem cells & the response of the immune system. Translating basic biomedical research findings directed at acquired and inherited diseases into potential therapeutic applications.

Dr. Anushree Chatterjee
Dr. Anushree Chatterjee

is an Assistant Professor of Chemical and Biological Engineering, University of Colorado Boulder, USA. Her research is on adopting integrated computational, systems and synthetic biology approaches to investigate molecular mechanisms for antibiotic and antiviral resistance, and construction of synthetic genetic devices for biotechnological and bioenergy applications.

Dr. Rob W.J. Collin
Dr. Rob W.J. Collin

is an Assistant Professor within the Department of Human Genetics, Radboud University Nijmegen Medical Center, The Netherlands. His research work involves the development of antisense-oligonucleotide (AON)-based therapy for inherited retinal dystrophies by employing various cell-based and animal models.

Dr. Pablo E. Vivas-Mejia
Dr. Pablo E. Vivas-Mejia

is an Assistant Professor, Department of Biochemistry & Cancer Center, Medical Sciences Campus, University of Puerto Rico, USA. His research is to understand the mechanisms by which cancer cells become resistant to chemotherapy, to design nanoliposome-based drug carriers, design and test microRNA and small interference RNA (siRNA)- therapies for advanced cancers.

Dr. Federica Montanaro
Dr. Federica Montanaro

is an Assistant Professor, Department of Pediatrics, Ohio State University College of Medicine & Principal Investigator, Center for Gene Therapy, Nationwide Children’s Hospital, USA. Her research focuses on defining signaling pathways & cellular responses that are dysregulated in Duchenne muscular dystrophy, with the goal of identifying targets for therapeutic intervention.

Dr. Gorbatyuk
Dr. Gorbatyuk

is an Assistant professor at the Department of Molecular Genetics and Microbiology at the University of Florida College of Medicine, USA. The major focus of his research is to determine the role and therapeutic potential of the activated Unfolded Protein Response during PD progression.

Dr. Shawn Wettig
Dr. Shawn Wettig

is an Assistant Professor in School of Pharmacy, University of Waterloo, USA. His research focuses on physical chemistry, solution thermodynamics, biochemistry and cell biology applied to the study of self-assembling systems which provide enhanced pharmaceutical applications such as targeted delivery and/or enhanced bio-distribution of an active compound.

Dr. Sandeep Kumar Kar
Dr. Sandeep Kumar Kar

is an Assistant Professor, Super specialty department of Cardiac anaesthesiology, Institute of Postgraduate Medical Education & Research, and Kolkata, India. He has represented India in several world congresses in Anaesthesiology and Critical Care.

Dr. Yangchao Chen
Dr. Yangchao Chen

is currently working as an Assistant Professor at the School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, China. His research interests include the investigation of mechanism and the functional significance of the dys-regulated genes and non-coding RNAs in liver and pancreatic cancer.

Dr. Cynthia Xiaohua Jiang
Dr. Cynthia Xiaohua Jiang

is an Assistant Professor at the school of biomedical sciences, the Chinese University of Hong Kong, China. Her research interest focused on the interface of stem cell biology and cancer, studying the mechanisms that regulate the function of stem cells and the ways in which those mechanisms are hijacked by cancer cells to generate tumors.

Dr. Nasrin Salehi
Dr. Nasrin Salehi

is a Research Assistant at Michigan Technological University, USA. Her research focuses on Biochemistry and molecular biology, Drug/ Gene delivery, Cancer, Parasitic disease, Bio-engineering, Pharmaceutical, Targeting therapeutic carriers for cancer treatment and new methods in diagnosis and treatment of diseases.

Dr. Chee Kai Chan
Dr. Chee Kai Chan

is a Lecturer in Department of Genetics, School of Molecular Sciences, Faculty of Science and Technology at La Trobe University, Australia. His lab works on novel non-viral vectors for gene therapy focusing on the use of ultrasound, nuclear targeting and nanoparticle encapsulation to enhance gene and drugs delivery; using Thalassemia as a disease model.

Dr. Yujing Li
Dr. Yujing Li

received his Ph.D from Institute of Genetics, Chinese academy of Sciences, Beijing,China. Currently He is senior scientist at the Department of human Genetics, Emory University School of Medicine, USA. His research interests are molecular genetics, neuroscience, epigenetics as well as the chemical biology approach towards dissection of RNAi pathway.

Dr. Jun-Jie Chen
Dr. Jun-Jie Chen

is an Assistant Investigator at the Tumor research laboratory, department of medical research, E-da hospital in Kaohsiung, Taiwan. He also served Adjunct Professor in I-Shou University, school of medicine. His area of interests focuses on signal transduction, cell death regulation, cancer therapeutics, drug resistance mechanisms and cancer biomarkers.

Dr. Jin Yang
Dr. Jin Yang

is currently working in Division of Cardiovascular Medicine, Stanford University, California. His research are novel signaling and transcriptional regulatory events that underlie the cardiac growth response in adult heart in response to pathologic stimuli such as hypertension and genetic mutations. His current research is based on mechanisms of fetal gene activation in adult cardiovascular diseases.

Dr. Zhiming Tu
Dr. Zhiming Tu

is currently working in the School of Life Science and Technology, Huazhong University of Science and Technology, China. Dr. Tu’s research interests focus on isolation and identification of genes and theirs promoters, gene diagnosis and gene therapy and studying mechanism of Traditional Chinese medicine and its modernization.

Dr. Kishor Sarkar
Dr. Kishor Sarkar

is an Assistant Professor in the Department of Polymer Science & Technology at the University of Calcutta, India. His research area of interest lies in the developing of various polymeric nonviral vectors for gene therapy application and development of novel bio polymer through living polymerization for tissue engineering in conjugation with gene delivery.

Dr. Deepak Godara
Dr. Deepak Godara

is the Director of  Research Institute of Biomedical and Industrial Research, Jaipur, India. He filed five Indian patents for his research work on nephrolithiasis and obesity. His research area focuses on isolation of capparisterol and development of genetic mechanism to eradicate obesity. He is Senior advisor for Academic Industry development program.